Immunology of Human Papillomaviruses

Front Matter....Pages i-xi
The Antibody Response Against P53 in Cancer Patients....Pages 1-7
Enhanced Production of Wild-Type P53 Inhibits Growth and Differentiation of Normal Foreskin Epithelial Cells but not Cell Lines Containing Human Papillomavirus DNA....Pages 9-14
Detection of Human Papillomavirus, Epstein Barr Virus and Elevated or Mutant P53 Expression in Squamous Cell Carcinoma of the Head and Neck....Pages 15-20
Elevated Levels of the P53 Tumour Suppressor Protein in the Basal Layer of Recurrent Laryngeal Papillomas....Pages 21-24
Expression of the E6 and E7 Genes of Human Papillomaviruses in Tumors of Different Dignity....Pages 25-31
Detection of HPV-16 E2 Protein in Cervical Keratinocytes....Pages 33-38
Evaluation of the Hybrid Capture Assay for Determination of Human Papilloma Virus....Pages 39-43
Utilization of a PCR-Based, Multiple Restriction Endonuclease Digest Technique for Enhanced Detection and Typing of HPV from Clinical Samples....Pages 45-49
A Gene Cassette for High Level Expression of the Li Capsid Protein of HPV-16 in Heterologous Cells....Pages 51-54
Genotyping of Human Papillomavirus (HPV) by Single-Strand Conformational Polymorphism (SSCP)....Pages 55-58
Human Papillomavirus Infection in Women with Cervical Cancer but without Cytological Abnormalities in the Preceding Years....Pages 59-62
HPV Infection and Carcinomas of the Larynx....Pages 63-69
Perinatal Transmission and Persistence of the Cancer Associated Human Papillomaviruses....Pages 71-74
HPV-DNA on Colpocytological Smears from HIV Positive Females....Pages 75-80
Humoral Immune Response to Genital Human Papillomavirus Infections....Pages 81-84
HPV16 Antibodies in Cervical Cancer Patients and Healthy Control Women....Pages 85-90
Prevalence of Antibodies Against Defined HPV Epitopes Among Incident Cases of Cervical Neoplasia: Current Status and Concepts....Pages 91-101
Serological Response to HPV16 Infection....Pages 103-107
Detection of Antibodies to LI, L2, and E4 Gene Products of Human Papillomavirus Types 6, 11, and 16 Among HPV Infected Patients and Controls....Pages 109-111
IgG Antibodies to Human Papillomavirus Type 16 and Serum Retinol May Jointly Protect Against Cervical Neoplasia....Pages 113-118
Prognostic Significance of Antibodies to HPV-16 E7 /E4 Proteins and Fragments of Cytokeratin 19 in Invasive Cervical Carcinoma....Pages 119-123
Development of Serological Assays for Detection of ANTI-HPV-16 E6 and E7 Antibodies....Pages 125-132
Detection by Elisa Test of Antibodies to Human Papillomavirus (HPV) Type 16 E7 Oncoprotein in Patients with Benign or Malignant Papillomas from Skin or Mucosa....Pages 133-138
Seroreactivity to a L2-Derived Synthetic Peptide Correlates with the Number of Surgery-Necessitating Recurrences in Patients with Laryngeal Papillomatosis....Pages 139-145
Comparison of PV Conformational Epitopes Expressed by L1 Proteins in Mammalian (COS) and Insect (SF9) Cells....Pages 147-153
Detection of Class-Specific Antibodies to Baculovirus-Derived Human Papillomavirus Type 16 (HPV-16) Capsid Proteins....Pages 155-160
Evolution of Class I HLA Antigen Presenting Molecules....Pages 161-172
Major Histocompatibility Complex (MHC) Expression and Antigen Presentation in Cervical Cancer....Pages 173-179
Analysis of MHC Class I Expression in HPV 16 Positive Cervical Carcinomas, in Relation to C- MYC Overexpression....Pages 181-188
Immunogenetic Study of Women with HPV Related Cancer of the Uterine Cervix....Pages 189-193
Recurrent Respiratory Papillomatosis (RRP): Enriched HLA DQw3 Phenotype and Decreased Class I MHC Expression....Pages 195-200
HPV 16-Derived Synthetic Peptides with Ability to Upregulate MHC Class I Expression on RMA-S or T2 Cells, as Detected by Enzyme Immunoassay....Pages 201-205
Regulation of MHC Class I, Class II and ICAM-1 Expression by Cytokines and Retinoids in HPV-Harboring Keratinocyte Lines....Pages 207-211
Murine Cytotoxic T Cell Responses to Human Papillomavirus E7 Protein....Pages 213-218
Immune Response to Human Papillomavirus Type 16 E6 Oncoprotein....Pages 219-226
Human Cytotoxic T Cell Epitopes in HPV 11: Relationships between Allele-Specific Motifs, HLA Binding, and Stimulation in Vitro....Pages 227-232
An Immunodominant Region in HPV16.L1 Identified by T Cell Responses in Patients with Cervical Dysplasias....Pages 233-241
Immunological Aspects of Cervical Carcinoma....Pages 243-248
Analysis of Tumour-Infiltrating Lymphocytes in Cervical Carcinoma....Pages 249-253
Lymphocyte-Mediated Natural Cytotoxicity to HPV16 Infected Cervical Keratinocytes....Pages 255-258
Skin Test Reactivity to Papilloma Cells is Long Lasting in Domestic Rabbits after Regression of Cottontail Rabbit Papillomavirus Induced Papillomas....Pages 259-265
Modulation of the DTH Response to HPV 16 E7....Pages 267-274
Fine Characterization of the HPVI6 E7 49-57 Tumor Protective Cytotoxic T Cell Epitope “Rahynivtf”....Pages 275-281
Vaccination of Cattle with L2 Protein Prevents BPV-4 Infection....Pages 283-290
Immune Responses to HPV 16 E7....Pages 291-297
Use of Double Aro Salmonella Mutants to Stably Express HPV16 E7 Protein Epitopes Carried by HBV Core Antigen....Pages 299-303
An Experimental Tetracyclin and Vitamin a Therapy of HPV Infections of the Lower Female Genital Tract....Pages 305-308
Retinoids and Ifnα Synergistically Decrease Tumor Cell-Induced Angiogenesis and Stimulate Lymphocyte Induced Angiogenesis....Pages 309-313
Release of Soluble Tumor Necrosis Factor-α (TNF-α) Receptor by HPV-Associated Neoplastic Cells....Pages 315-320
Back Matter....Pages 321-332